Heart Test Laboratories (HSCS) EBITDA (2021 - 2026)
Heart Test Laboratories (HSCS) EBITDA from Jul 31, 2021 to Jan 31, 2026. The TTM Heart Test Laboratories (HSCS) EBITDA is -$7.79M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Heart Test Laboratories (HSCS) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -5.58% |
| 3 Years TTM | +6.44% |
| All Time TTM | +10.79% |
Annual EBITDA change of Heart Test Laboratories (HSCS)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$1.92M | -76.90% |
| 2025 | -$8.31M | +32.32% |
| 2024 | -$6.28M | +3.12% |
| 2023 | -$6.09M | +30.13% |
| 2022 | -$4.68M | +187.12% |
| 2021 | -$1.63M | N/A |